262 related articles for article (PubMed ID: 21383592)
21. Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase.
Matsui T; Svensson CI; Hirata Y; Mizobata K; Hua XY; Yaksh TL
Anesth Analg; 2010 Aug; 111(2):554-60. PubMed ID: 20610553
[TBL] [Abstract][Full Text] [Related]
22. Genistein inhibits Ang II-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPARγ-NF-κB signaling pathway in rat vascular smooth muscle cells.
Xu L; Liu JT; Li K; Wang SY; Xu S
Life Sci; 2019 Jan; 216():140-146. PubMed ID: 30452971
[TBL] [Abstract][Full Text] [Related]
23. EV71 induces VCAM-1 expression via PDGF receptor, PI3-K/Akt, p38 MAPK, JNK and NF-kappaB in vascular smooth muscle cells.
Tung WH; Sun CC; Hsieh HL; Wang SW; Horng JT; Yang CM
Cell Signal; 2007 Oct; 19(10):2127-37. PubMed ID: 17669626
[TBL] [Abstract][Full Text] [Related]
24. Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells.
Pang X; Liu J; Zhao J; Mao J; Zhang X; Feng L; Han C; Li M; Wang S; Wu D
Atherosclerosis; 2014 Sep; 236(1):73-81. PubMed ID: 25016361
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
Zhang W; Zhang Y; Edvinsson L; Xu CB
J Vasc Res; 2009; 46(2):162-74. PubMed ID: 18769070
[TBL] [Abstract][Full Text] [Related]
26. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.
Yuan X; Liu N
J Genet Genomics; 2011 May; 38(5):193-200. PubMed ID: 21621740
[TBL] [Abstract][Full Text] [Related]
27. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.
Kinsner A; Boveri M; Hareng L; Brown GC; Coecke S; Hartung T; Bal-Price A
J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
29. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.
Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K
Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043
[TBL] [Abstract][Full Text] [Related]
30. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.
Verma S; Kuliszewski MA; Li SH; Szmitko PE; Zucco L; Wang CH; Badiwala MV; Mickle DA; Weisel RD; Fedak PW; Stewart DJ; Kutryk MJ
Circulation; 2004 May; 109(17):2058-67. PubMed ID: 15078802
[TBL] [Abstract][Full Text] [Related]
32. 17beta-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells.
Jiang P; Xu J; Zheng S; Huang J; Xiang Q; Fu X; Wang T
J Mol Endocrinol; 2010 Aug; 45(2):87-97. PubMed ID: 20538789
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin inhibits homocysteine-induced CRP generation via interfering with the ROS-p38/ERK1/2 signal pathway in rat vascular smooth muscle cells.
Pang X; Si J; Xu S; Li Y; Liu J
Vascul Pharmacol; 2017 Jan; 88():42-47. PubMed ID: 27993685
[TBL] [Abstract][Full Text] [Related]
34. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
35. 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells.
Ichiki T; Tokunou T; Fukuyama K; Iino N; Masuda S; Takeshita A
Biochem Biophys Res Commun; 2004 Oct; 323(2):402-8. PubMed ID: 15369766
[TBL] [Abstract][Full Text] [Related]
36. Rosiglitazone reduces the inflammatory response in a model of vascular injury in rats.
Rinaldi B; Pieri L; Donniacuo M; Cappetta D; Capuano A; Domenici L; Carnuccio R; Romagnoli P; Filippelli A; Rossi F
Shock; 2009 Dec; 32(6):638-44. PubMed ID: 19333142
[TBL] [Abstract][Full Text] [Related]
37. Rosiglitazone suppresses lipopolysaccharide-induced matrix metalloproteinase-2 activity in rat aortic endothelial cells via Ras-MEK1/2 signaling.
Wu X; Li L
Int J Cardiol; 2012 Jun; 158(1):54-8. PubMed ID: 21247645
[TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
[TBL] [Abstract][Full Text] [Related]
39. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
40. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
Yamamoto A; Kakuta H; Sugimoto Y
Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
